In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer.
Anticancer Agents Med Chem
; 23(19): 2111-2126, 2023.
Article
in En
| MEDLINE
| ID: mdl-37287303
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Achyranthes
/
Proto-Oncogene Proteins B-raf
/
GTP Phosphohydrolases
/
Membrane Proteins
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Anticancer Agents Med Chem
Journal subject:
ANTINEOPLASICOS
/
QUIMICA
Year:
2023
Document type:
Article
Affiliation country: